- call +1-201-465-4211
- email sales@mrinsights.biz
Antacids are over-the-counter medications that help neutralize stomach acid. They work differently from other acid reducers such as H2-receptor blockers or proton pump inhibitors, which work by reducing or preventing the secretion of stomach acid.
Scope of the Report:
This report focuses on the Antacids in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Antacids is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
WellSpring Pharm
Private Lable
GSK
Johnson & Johnson
Novartis Consurmer Health
Boehringer Ingelheim Pharm
GlaxoSmithKline
Procter & Gamble
Pfizer
First Aid Only
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Proton Pump Inhibitor
H2 Antagonist
Acid Neutralizers
Market Segment by Applications, can be divided into
Tablet
Liquid
Powder
There are 15 Chapters to deeply display the global Antacids market.
Chapter 1, to describe Antacids Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antacids, with sales, revenue, and price of Antacids, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antacids, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Antacids market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Antacids sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Antacids Introduction
1.2 Market Analysis by Type
1.2.1 Proton Pump Inhibitor
1.2.2 H2 Antagonist
1.2.3 Acid Neutralizers
1.3 Market Analysis by Applications
1.3.1 Tablet
1.3.2 Liquid
1.3.3 Powder
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 WellSpring Pharm
2.1.1 Business Overview
2.1.2 Antacids Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 WellSpring Pharm Antacids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Private Lable
2.2.1 Business Overview
2.2.2 Antacids Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Private Lable Antacids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GSK
2.3.1 Business Overview
2.3.2 Antacids Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GSK Antacids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Antacids Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Antacids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis Consurmer Health
2.5.1 Business Overview
2.5.2 Antacids Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Consurmer Health Antacids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Boehringer Ingelheim Pharm
2.6.1 Business Overview
2.6.2 Antacids Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boehringer Ingelheim Pharm Antacids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 GlaxoSmithKline
2.7.1 Business Overview
2.7.2 Antacids Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GlaxoSmithKline Antacids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Procter & Gamble
2.8.1 Business Overview
2.8.2 Antacids Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Procter & Gamble Antacids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Antacids Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Antacids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 First Aid Only
2.10.1 Business Overview
2.10.2 Antacids Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 First Aid Only Antacids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Antacids Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Antacids Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antacids Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Antacids Manufacturer Market Share in 2017
3.3.2 Top 6 Antacids Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Antacids Market Analysis by Regions
4.1 Global Antacids Sales, Revenue and Market Share by Regions
4.1.1 Global Antacids Sales and Market Share by Regions (2013-2018)
4.1.2 Global Antacids Revenue and Market Share by Regions (2013-2018)
4.2 North America Antacids Sales and Growth Rate (2013-2018)
4.3 Europe Antacids Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antacids Sales and Growth Rate (2013-2018)
4.5 South America Antacids Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antacids Sales and Growth Rate (2013-2018)
5 North America Antacids by Countries
5.1 North America Antacids Sales, Revenue and Market Share by Countries
5.1.1 North America Antacids Sales and Market Share by Countries (2013-2018)
5.1.2 North America Antacids Revenue and Market Share by Countries (2013-2018)
5.2 United States Antacids Sales and Growth Rate (2013-2018)
5.3 Canada Antacids Sales and Growth Rate (2013-2018)
5.4 Mexico Antacids Sales and Growth Rate (2013-2018)
6 Europe Antacids by Countries
6.1 Europe Antacids Sales, Revenue and Market Share by Countries
6.1.1 Europe Antacids Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Antacids Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antacids Sales and Growth Rate (2013-2018)
6.3 UK Antacids Sales and Growth Rate (2013-2018)
6.4 France Antacids Sales and Growth Rate (2013-2018)
6.5 Russia Antacids Sales and Growth Rate (2013-2018)
6.6 Italy Antacids Sales and Growth Rate (2013-2018)
7 Asia-Pacific Antacids by Countries
7.1 Asia-Pacific Antacids Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Antacids Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Antacids Revenue and Market Share by Countries (2013-2018)
7.2 China Antacids Sales and Growth Rate (2013-2018)
7.3 Japan Antacids Sales and Growth Rate (2013-2018)
7.4 Korea Antacids Sales and Growth Rate (2013-2018)
7.5 India Antacids Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antacids Sales and Growth Rate (2013-2018)
8 South America Antacids by Countries
8.1 South America Antacids Sales, Revenue and Market Share by Countries
8.1.1 South America Antacids Sales and Market Share by Countries (2013-2018)
8.1.2 South America Antacids Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antacids Sales and Growth Rate (2013-2018)
8.3 Argentina Antacids Sales and Growth Rate (2013-2018)
8.4 Colombia Antacids Sales and Growth Rate (2013-2018)
9 Middle East and Africa Antacids by Countries
9.1 Middle East and Africa Antacids Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antacids Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Antacids Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antacids Sales and Growth Rate (2013-2018)
9.3 UAE Antacids Sales and Growth Rate (2013-2018)
9.4 Egypt Antacids Sales and Growth Rate (2013-2018)
9.5 Nigeria Antacids Sales and Growth Rate (2013-2018)
9.6 South Africa Antacids Sales and Growth Rate (2013-2018)
10 Global Antacids Market Segment by Type
10.1 Global Antacids Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Antacids Sales and Market Share by Type (2013-2018)
10.1.2 Global Antacids Revenue and Market Share by Type (2013-2018)
10.2 Proton Pump Inhibitor Sales Growth and Price
10.2.1 Global Proton Pump Inhibitor Sales Growth (2013-2018)
10.2.2 Global Proton Pump Inhibitor Price (2013-2018)
10.3 H2 Antagonist Sales Growth and Price
10.3.1 Global H2 Antagonist Sales Growth (2013-2018)
10.3.2 Global H2 Antagonist Price (2013-2018)
10.4 Acid Neutralizers Sales Growth and Price
10.4.1 Global Acid Neutralizers Sales Growth (2013-2018)
10.4.2 Global Acid Neutralizers Price (2013-2018)
11 Global Antacids Market Segment by Application
11.1 Global Antacids Sales Market Share by Application (2013-2018)
11.2 Tablet Sales Growth (2013-2018)
11.3 Liquid Sales Growth (2013-2018)
11.4 Powder Sales Growth (2013-2018)
12 Antacids Market Forecast (2018-2023)
12.1 Global Antacids Sales, Revenue and Growth Rate (2018-2023)
12.2 Antacids Market Forecast by Regions (2018-2023)
12.2.1 North America Antacids Market Forecast (2018-2023)
12.2.2 Europe Antacids Market Forecast (2018-2023)
12.2.3 Asia-Pacific Antacids Market Forecast (2018-2023)
12.2.4 South America Antacids Market Forecast (2018-2023)
12.2.5 Middle East and Africa Antacids Market Forecast (2018-2023)
12.3 Antacids Market Forecast by Type (2018-2023)
12.3.1 Global Antacids Sales Forecast by Type (2018-2023)
12.3.2 Global Antacids Market Share Forecast by Type (2018-2023)
12.4 Antacids Market Forecast by Application (2018-2023)
12.4.1 Global Antacids Sales Forecast by Application (2018-2023)
12.4.2 Global Antacids Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Antacids Picture
Table Product Specifications of Antacids
Figure Global Sales Market Share of Antacids by Types in 2017
Table Antacids Types for Major M
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
